Publications found:
251,903
Sort by:
Emerging Coagulation Tests and Suppliers Developing New Technologies
US$ 1,480.00
The report presents an overview of the clinical significance and market needs for major coagulation laboratory tests, as well as extensive listings of companies developing or marketing new coagulation technologies and products. Contains 125 pages and 20 tables
December 2011
125 pages
Emerging Cancer Molecular Diagnostic Tests
US$ 1,160.00
The report presents an overview of the clinical significance and market needs for major tumor markers, as well as listings of companies developing and marketing molecular diagnostic technologies and products for cancer testing. Contains 45 pages and 1 table
December 2011
45 pages
Kraft Foods inc in Health and Wellness (World)
US$ 572.00
... the wake of the Cadbury acquisition, Kraft Foods nearly doubled its global health and wellness (HW) sales to US$16.5 billion in ... its portfolio development with key wellness trends. Euromonitor International’s Kraft Foods Inc in Health and Wellness (World) Company Profile offers detailed strategic ...
December 2011
49 pages
European Markets for Orthopedic Large Joint Reconstructive Devices 2011
US$ 11,495.00
In 2010, the combined European large joint orthopedic reconstruction device market was valued at over €1.9 billion. The countries covered in this report include ... include: The knee reconstruction market The hip reconstruction market The bone cement market Within the orthopedic large joint replacement and ...
December 2011
316 pages
Outlook 2012 - Rising Stars - Innovators Deliver but Rewards Not Guranteed!
US$ 2,000.00
... continue to flow from the backyards of small research focused companies (Rising stars, RS) but commercial success of launched products is not assured despite patents ... Micromet (MITI) are our Top Picks for FY2012 in the Rising Stars Sector. Key drugs of ANTH and MITI target high unmet ...
December 2011
52 pages
Competitor Analysis: HIV Small Molecule Therapeutics
US$ 642.00
The present Competitive Intelligence report about HIV Small Molecule Therapeutics used to treat human immunodeficiency virus (HIV) infections provides a competitor evaluation in the field of marketed...
December 2011
100 pages
Outlook 2012 - Mature Biotech - Investing in Growth and Value buys!
US$ 2,000.00
... ’ in 2011! We expect a similar trend of acquisitions and in-licensing of better molecules in 2012 and beyond, as MB companies have robust cash flow to further leverage ... Gilead (GILD) are our Top Picks for FY2012 in the Mature Biotech Sector. BIIB’s focus and leadership in the MS market and positive ...
December 2011
46 pages
Outlook 2012 - Japanese Pharma - Cautious Ideas to Seize Value in Happening 2012!
US$ 2,000.00
‘Japanese Pharma Top & Bottom Picks’. Our analysis suggests that 2012 is going to be a happening year for Japan Pharma on multiple fronts – while next layer of reform ... largely supporting generic companies, select innovators from Japan hold value in term of their R&D. 2012 will unfold much of this value and ...
December 2011
78 pages
NOVARTIS - Tekturna: ALTITUDE study in high risk hypertensive patients TERMINATED
US$ 90.00
... the termination of large PhIII study (ALTITUDE) due to higher rate of adverse events and no benefits observed for patients taking Tekturna in addition to ACE ... inhibitors. Post this announcement, NVS will cease promotion of Tekturna/Tekturna products in combination with ACE inhibitors/ARB inhibitors. The event ...
December 2011
1 pages
LUPIN - Lupin - Loss of 2 Exclusivities Further Exposes the weak Pipeline
US$ 140.00
... . Most glaring is the Fortmet case, where Lupin launched the product ‘at-risk’ and later withdrew ... settled with Lupin it cannot launch its generic version (unless ‘at-risk’) thereby leading to a loss of this ... shared 180-day exclusivity for Lupin. These add to the pressure ...
December 2011
3 pages
Cardiac Rhythm Management Devices: World Market Outlook 2011-2021
US$ 2,635.00
... decisions. The market will change with the launch of new products such as devices suitable for use with MRI and biological pacemakers. Find R&D trends ... (shown in the accompanying lists). Why you should buy Cardiac Rhythm Management Devices: World Market Outlook 2011-2021 In this report, you will receive ...
December 2011
145 pages
MSL-KOL Engagement: Measuring Success
US$ 595.00
It’s difficult to quantify. Its role constantly changes. And despite all efforts to gain transparency, the field of medical science liaison (MSL) remains an elusive—seemingly immeasurable—yet undeniab...
November 2011
26 pages
Assessment of the fast growing Indian Biotech Market
US$ 800.00
... The country is a favored destination in custom research outsourcing and custom manufacturing outsourcing (CMO). Growth in the sector is likely to come from India's strong position in biosimilars, molecular diagnostics and personalized medicine. However, the industry is also facing various challenges such as ...
November 2011
30 pages
Vertex – “Testing Time Ahead for INCIVEK - After 2013!”
US$ 140.00
... in 2014, would result in declining sales for INCIVEK/IFN combination. Vertex (VRTX) next target is to capture the HCV/HIV co-infected patients ... read our report released on 25th November, 2011 on VRTX titled “Testing Time Ahead for INCIVEK - After 2013!”
November 2011
10 pages
Generic Drug Market in Canada
US$ 1,000.00
Canada is one of the world’s largest pharmaceutical markets, even though it has a low share of only 3% in global pharma industry. In 2010, generics accounted for more than 57% prescriptions and around...
November 2011
65 pages
US Glucose Monitoring Market Analysis
US$ 1,000.00
The US has a dominant share in the global diabetes market with 90-95% of the diabetic patients in the country suffering from type-II diabetes. Factors like, high prevalence of diabetes, rising aging p...
November 2011
55 pages
Medical Imaging Markets: X-Ray, Digital X-Ray, CT and Other Radiography Systems
US$ 3,500.00
... are among the factors driving these imaging markets. This report, Medical Imaging Markets: X-Ray, Digital X-Ray, CT and Other Radiography Systems from ... based systems to filmless environments. At the same time there are practical limiters to digital and areas where film-based systems will still be useful, ...
November 2011
150 pages
World Market for Medical Beds
US$ 2,995.00
... Including: Acute Long Term Home Care Regional Medical Bed Markets: US Europe Asia Rest of World There are several primary issues and ... Purchases Increasing Incidence of Disease Results of Recent Acquisitions Healthcare Reform Bed Safety and Safety Rail Issues Insurance and Reimbursement The ...
November 2011
150 pages
World Market for Prescription Arthritis Treatments
US$ 3,500.00
... management. This Kalorama Information report, The World Market for Prescription Arthritis Treatments, details the market for these treatments. The report provides ... There are several issues and trends that are shaping this market. Some of the topics, discussed in this report include: US Economic Impact ...
November 2011
150 pages
U.S. Market for Arthroscopic Devices 2011
US$ 7,495.00
... was resurgence in procedures due tothe accumulated demand which drove arthroscopic device market growth. Within the soft tissue and sports medicine market, ... , ConMed Linvatec, DePuy Mitek, Smith & Nephew and Stryker lead the market, among many others. This report provides a comprehensive and detailed analysis ...
November 2011
European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive)
US$ 11,495.00
... replacing the natural lens when it has been damaged by cataracts. The market segments covered in this report include: Optical Coherence Tomographers Fundus ... Scandinavia Spain Switzerland The United Kingdom Within the European Ophthalmic device market, companies such as Alcon, AMO, Bausch & Lomb, Carl ...
November 2011
European Markets for Women’s Health Devices 2011
US$ 11,495.00
... 2010, the market for women’s health devices in Europe was valued at €667.6 million. The main conditions dealt with by women’s health professionals ... , and gynecologists move intourology and other surgery specialties. This European report covers: Austria, Benelux, France, Germany, Italy, Portugal, Spain ...
November 2011
Aloka in the Global Diagnostic Imaging Sector
US$ 1,520.00
A strategic assessment of Aloka, one of the world's leading diagnostic imaging companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's ...
November 2011
32 pages
Global Diagnostic Imaging Companies Financial Performance
US$ 1,960.00
Each company’s analysis provides: Sales estimates by division, geographic region, and modality. Five-year sales and operating profit performance. The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, Hologic, Philips, Shimadzu, Siemens, and Toshiba. Contains 92 pages and 78 tables
November 2011
92 pages
Global Diagnostic Imaging Companies M&A, Business Organizations, and Senior Management
US$ 1,480.00
... , divestitures, and significant organizational changes. Current organizational structure. Management philosophy and attitudes toward the diagnostic imaging market. Background of key executives. The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, Hologic, Philips, Shimadzu, Siemens, ...
November 2011
92 pages
Global Diagnostic Imaging Companies M&A, Joint Ventures, R&D Pipeline, and Strategies
US$ 10,000.00
... , factual, annually updated and cost-effective information base on performance, capabilities, goals and strategies of the world’s leading diagnostic imaging companies. To help current suppliers realistically assess their financial, technological and marketing capabilities vis-a-vis the leading competitors. ...
November 2011
850 pages
Global Diagnostic Imaging Companies Major Facilities and Employees
US$ 1,480.00
... , manufacturing, and R&D facilities in the U.S. and abroad. New plants under construction. U.S. and international work force size and distribution. The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, Hologic, Philips, Shimadzu, Siemens, and Toshiba. Contains 32 pages
November 2011
32 pages
Global Diagnostic Imaging Companies R&D Pipeline and Expenditures
US$ 1,480.00
... , research facilities, and staff. New technologies, systems, and applications in development, including their specifications and anticipated introduction dates. The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, Hologic, Philips, Shimadzu, Siemens, and Toshiba. Contains 40 pages
November 2011
40 pages
U.S. and European Markets for Orthopedic Trauma Devices by Anatomy 2011
US$ 11,495.00
... U.S. market, the largest in the world, comprised 76.2% of the combined market. The U.S. and European trauma markets comprise: external and internal fixation devices ... Finland, Denmark, Sweden and Norway), Spain, Switzerland, the United Kingdom Market sizes, unit sales and ASPs are presented for the ...
November 2011
158 pages
Multiple Sclerosis Treatment: World Drug Market 2012-2022
US$ 2,635.00
... tables and charts and three research interviews. Advantages of Multiple Sclerosis Treatment: World Drug Market 2012-2022 for your work Our ... , viewing sales growth Discover revenue forecasts to 2022 for leading MS drugs, assessing commercial potential Assess leading companies, discovering their activities ...
November 2011
116 pages
US Pharmacy Benefit Management (PBM) Industry Report: 2011 Edition
US$ 800.00
... chronic condition has also risen. The report analyzes the US Pharmacy Benefit Management Industry. Rising drug prices, increasing drug utilization and prevalence ... , contracts for renewals of the major players and market share of PBM companies adjusted on the basis of acquisitions and contract shifts. This ...
November 2011
40 pages
Competitor Analysis: Anti-Infective Antibodies
US$ 1,086.00
Product description The present Competitive Intelligence Report about Anti-Infective Antibodies provides a competitor evaluation in the field of recombinant monoclonal and polyclonal antibodies and human plasma-derived immunoglobulins and hyperimmunes for post-exposure prophylaxis and treatment of ...
November 2011
160 pages
Global Orthopedics Devices Market (2011 – 2016)
US$ 5,650.00
... in this market. This report forecasts the size of global orthopedic devices market from 2011 to 2016. The report analyzes key trends of the market, and segments the global orthopedics market ... with more than 100 market data tables. Scope of the report Global Orthopedic Devices Market research report categorizes the global market on the basis of devices, and geography; forecasting ...
November 2011
188 pages
Orthopedic Implants - A Global Market Overview
US$ 4,050.00
Description: “Fit and Forget” is a fundamental requirement in several critical applications, and human body implants are a part and parcel of this challenging requirement. The number of people underg...
November 2011
197 pages
GALAPAGOS - Waiting for Santa!
US$ 90.00
... , please read our report released on 22nd November on GLPG titled “Waiting for Santa”!
November 2011
3 pages
PHARMASSET - "IFN-free Oral Option" for HCV- Sharing the Big Pie!
US$ 140.00
Pharmasset (VRUS) may enjoy the first mover advantage in the race to offer the first “IFN free all oral option” to HCV pts. However the window ... read our report released on Nov. 16th, 2011 on VRUS titled “IFN-free Oral Option” for HCV- Sharing the Big Pie!
November 2011
9 pages
